234 related articles for article (PubMed ID: 24574780)
1. Phase I study of postoperative radiotherapy combined with capecitabine for gastric cancer.
Wang X; Jin J; Li YX; Ren H; Fang H; Wang SL; Liu YP; Wang WH; Yu ZH; Song YW; Liu XF
World J Gastroenterol; 2014 Jan; 20(4):1067-73. PubMed ID: 24574780
[TBL] [Abstract][Full Text] [Related]
2. Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy.
Jansen EP; Boot H; Dubbelman R; Bartelink H; Cats A; Verheij M
Br J Cancer; 2007 Sep; 97(6):712-6. PubMed ID: 17848909
[TBL] [Abstract][Full Text] [Related]
3. Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy.
Jansen EPM; Boot H; Dubbelman R; Verheij M; Cats A
Ann Oncol; 2010 Mar; 21(3):530-534. PubMed ID: 19690058
[TBL] [Abstract][Full Text] [Related]
4. A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer.
Jansen EP; Boot H; Saunders MP; Crosby TD; Dubbelman R; Bartelink H; Verheij M; Cats A
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1424-8. PubMed ID: 17689023
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.
Chakravarty T; Crane CH; Ajani JA; Mansfield PF; Briere TM; Beddar AS; Mok H; Reed VK; Krishnan S; Delclos ME; Das P
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):581-6. PubMed ID: 22137021
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of postoperative radiotherapy concurrent with S-1 in patients with gastric cancer.
Qiu M; Peng XC; Bi F; Wang X; Li Q; Xu F; Li ZP; Shen YL; Liu JY; Zhao YQ; Cao D; Gou HF; Yang Y; Chen Y; Yi C
Med Oncol; 2015 Jul; 32(7):191. PubMed ID: 26025485
[TBL] [Abstract][Full Text] [Related]
7. A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma.
Evans TR; Pentheroudakis G; Paul J; McInnes A; Blackie R; Raby N; Morrison R; Fullarton GM; Soukop M; McDonald AC
Ann Oncol; 2002 Sep; 13(9):1469-78. PubMed ID: 12196374
[TBL] [Abstract][Full Text] [Related]
8. Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study.
Morganti AG; Picardi V; Ippolito E; Massaccesi M; Macchia G; Deodato F; Mattiucci GC; Caravatta L; Di Lullo L; Giglio G; Tambaro R; Mignogna S; Caprino P; Ingrosso M; Sofo L; Cellini N; Valentini V
Acta Oncol; 2010 May; 49(4):418-22. PubMed ID: 20397772
[TBL] [Abstract][Full Text] [Related]
9. [Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer].
Jin J; Li YX; Liu YP; Wang WH; Li T; Li N; Song YW
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):393-6. PubMed ID: 17045010
[TBL] [Abstract][Full Text] [Related]
10. Postoperative chemoradiotherapy in gastric cancer: a phase I study of radiotherapy with dose escalation of oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX regimen).
Wang X; Wang Y; Qiu M; Li Q; Li ZP; He B; Xu F; Shen YL; Gou HF; Yang Y; Cao D; Yi C; Liu JY; Luo DY; Liao ZY; Bi F
Med Oncol; 2011 Dec; 28 Suppl 1():S274-9. PubMed ID: 21116880
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated image-guided IMRT in advanced pancreatic cancer with simultaneous integrated boost to infiltrated vessels concomitant with capecitabine: a phase I study.
Passoni P; Reni M; Cattaneo GM; Slim N; Cereda S; Balzano G; Castoldi R; Longobardi B; Bettinardi V; Gianolli L; Gusmini S; Staudacher C; Calandrino R; Di Muzio N
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1000-6. PubMed ID: 24267968
[TBL] [Abstract][Full Text] [Related]
12. Image-guided intensity-modulated radiotherapy for patients with locally advanced gastric cancer: a clinical feasibility study.
Badakhshi H; Gruen A; Graf R; Boehmer D; Budach V
Gastric Cancer; 2014; 17(3):537-41. PubMed ID: 24122094
[TBL] [Abstract][Full Text] [Related]
13. Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study.
Zhu J; Liu F; Gu W; Lian P; Sheng W; Xu J; Cai G; Shi D; Cai S; Zhang Z
Radiat Oncol; 2014 Mar; 9():70. PubMed ID: 24606870
[TBL] [Abstract][Full Text] [Related]
14. A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma.
Zhu J; Gu W; Lian P; Sheng W; Cai G; Shi D; Cai S; Zhang Z
Radiat Oncol; 2013 May; 8():130. PubMed ID: 23718210
[TBL] [Abstract][Full Text] [Related]
15. Chronomodulated capecitabine and adjuvant radiation in intermediate-risk to high-risk rectal cancer: a phase II study.
Bajetta E; Pietrantonio F; Buzzoni R; Ferrario E; Valvo F; Mariani L; Dotti KF; Biondani P; Formisano B; Gevorgyan A; Grassi P; Di Bartolomeo M
Am J Clin Oncol; 2014 Dec; 37(6):545-9. PubMed ID: 23428953
[TBL] [Abstract][Full Text] [Related]
16. A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer.
Ngan SY; Michael M; Mackay J; McKendrick J; Leong T; Lim Joon D; Zalcberg JR
Br J Cancer; 2004 Sep; 91(6):1019-24. PubMed ID: 15305186
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
[TBL] [Abstract][Full Text] [Related]
18. Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial).
Veerasarn V; Phromratanapongse P; Lorvidhaya V; Lertsanguansinchai P; Lertbutsayanukul C; Panichevaluk A; Boonnuch W; Chinswangwatanakul V; Lohsiriwat D; Rojanasakul A; Thavichaigarn P; Jivapaisarnpong P
J Med Assoc Thai; 2006 Nov; 89(11):1874-84. PubMed ID: 17205868
[TBL] [Abstract][Full Text] [Related]
19. Multicenter phase II clinical trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer.
de las Heras M; Arias F; del Moral-Avila R; Gómez-Millán J; Jiménez E; Wals A; Tisaire JL; Alcantara MP
Clin Transl Oncol; 2013 Apr; 15(4):294-9. PubMed ID: 22855196
[TBL] [Abstract][Full Text] [Related]
20. [Phase I study of capecitabine with concurrent radiotherapy in early-stage nasopharyngeal carcinoma].
Guo L; Lin HX; Li FY; Li Q; Qiu F; Luo DH; Guo X; Hong MH
Zhonghua Zhong Liu Za Zhi; 2004 Apr; 26(4):250-3. PubMed ID: 15312392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
